BIOMAT Database Logo BIOMAT Database Logo

Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin. 1992

G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Connaught Centre for Biotechnology Research, Willowdale, Ontario, Canada.

Nontoxic analogs of pertussis toxin (PT), produced by in vitro mutagenesis of the tox operon, are immunogenic and protective against infection by Bordetella pertussis. The moderate levels of PT production by B. pertussis, however, make it the limiting antigen in the formulation of multicomponent, acellular, recombinant whooping cough vaccines. To increase production of the highly detoxified Lys9Gly129 PT analog by B. pertussis, additional copies of the mutated tox operon were integrated into the bacterial chromosome at the tox or fha locus by unmarked allelic exchange. Recombinant strains produced in this way secreted elevated levels of the PT analog proportional to gene dosage. The strains were stable during 10-liter fermentations, and yields of up to 80 mg of PT analog per liter were obtained under production-scale conditions. The nontoxic analog was purified and shown to be indistinguishable from material obtained from a B. pertussis strain that contained only a single copy of the toxLys9Gly129 operon. Such strains are therefore suitable for large-scale, industrial production of an acellular whooping cough vaccine containing a genetically detoxified PT analog.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009876 Operon In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION. Operons
D010566 Virulence Factors, Bordetella A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor. Bordetella Virulence Factors,Agglutinogen 2, Bordetella Pertussis,Bordetella Virulence Determinant,LFP-Hemagglutinin,LP-HA,Leukocytosis-Promoting Factor Hemagglutinin,Lymphocytosis-Promoting Factor-Hemagglutinin,Pertussis Agglutinins,Agglutinins, Pertussis,Determinant, Bordetella Virulence,Factor Hemagglutinin, Leukocytosis-Promoting,Factor-Hemagglutinin, Lymphocytosis-Promoting,Factors, Bordetella Virulence,Hemagglutinin, Leukocytosis-Promoting Factor,LFP Hemagglutinin,LP HA,Leukocytosis Promoting Factor Hemagglutinin,Lymphocytosis Promoting Factor Hemagglutinin,Virulence Determinant, Bordetella
D001886 Bordetella pertussis A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Bacterium tussis-convulsivae,Haemophilus pertussis,Hemophilus pertussis
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015139 Blotting, Southern A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Southern Blotting,Blot, Southern,Southern Blot
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction

Related Publications

G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
April 2012, BMC microbiology,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Construction and characterization of genetically inactivated pertussis toxin.
January 1991, Developments in biological standardization,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
January 1995, Physiological chemistry and physics and medical NMR,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
[Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
January 2010, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Construction and characterization of Bordetella pertussis toxin mutants.
October 1987, Infection and immunity,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.
August 2009, Emerging infectious diseases,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Secretion of Pertussis Toxin from Bordetella pertussis.
August 2021, Toxins,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
[Production of pertussis toxin by Bordetella pertussis strains isolated from patients with whooping cough].
January 2011, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Serotyping Bordetella pertussis strains.
December 1989, Vaccine,
G R Zealey, and S M Loosmore, and R K Yacoob, and S A Cockle, and A B Herbert, and L D Miller, and N J Mackay, and M H Klein
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.
March 1992, Infection and immunity,
Copied contents to your clipboard!